Reference no: EM13708443

Part 1: Present the comparison of clinical benefit of the use of long-acting somatostatin analogs or GH receptor antagonists. What is a primary advantage of GH receptor antagonists compared with long-acting somatostatin analogs?

Part 2: Present the most common measurements used in clinic to assess recovery of the hypothalamus-pituitary-adrenal axis in patients withdrawing from exogenous glucocorticoids.

Part 3: Compare the effects of the use of estrogen-only administration to the use of a progestin combined with an estrogen.

Part 4: Present the comparison of pharmacokinetic properties of agents used to promote insulin release to other agents used to treat diabetes, such as biguanides and thiazolidinediones.

Part 5: Present the most common side effects caused by the use of antacids, H2 receptor inhibitors, laxatives, proton pump inhibitors or other promotility drugs.